Telesky AC 40/5/12.5 Tablets provide an established, clinically unified triple-combination therapy carefully developed for the continuous management and physiological stabilization of severe, chronic, or stubborn essential Hypertension. When dual regimens or standard single-agent treatments fail to maintain optimal systemic baseline blood pressure targets, attacking cardiovascular dysfunction across multiple independent physiological loops is vital. This advanced oral formulation integrates three distinct, highly complementary anti-hypertensive agents to target arterial vascular resistance, cellular calcium influx, and fluid-volume excess simultaneously, preventing sudden blood pressure fluctuations.
The synchronized formulation operates dynamically across three distinct physiological fronts:
-
Telmisartan (40 mg): A highly selective angiotensin II type 1 ($AT_1$) receptor antagonist. It blocks the powerful vasoconstricting actions of angiotensin II, systematically relaxing arterial smooth muscle walls to drop peripheral vascular resistance without causing a reflex increase in heart rate.
-
Amlodipine (5 mg): A classic dihydropyridine calcium channel blocker (CCB). It works by inhibiting the transmembrane influx of extracellular calcium ions into vascular smooth muscle cells. This process actively prevents coronary and peripheral arterial contractions, expanding blood vessels to smoothly optimize blood flow profiles.
-
Chlorthalidone (12.5 mg): A potent, long-acting thiazide-like diuretic. It works inside the kidneys at the cortical diluting segment of the distal convoluted tubule, blocking the active reabsorption of sodium and chloride ($Na^+/Cl^-$ cotransporter). By increasing the excretion of sodium and water from the bloodstream, it actively decreases extracellular fluid volume and cardiac output, dropping baseline pressure metrics over a steady period.
Key Benefits
-
Maximum Strength Triple Action Control: Unites three independent cardiovascular mechanism tracks for intensive blood pressure regulation where dual configurations fail.
-
Synergistic Vascular Relaxation: The combined pathway of Telmisartan and Amlodipine provides a faster, longer-lasting defense against vascular constriction and arterial tightness.
-
Optimized Fluid Balancing Profile: The 12.5 mg Chlorthalidone component delivers excellent fluid extraction benefits, actively dropping fluid volume and lowering peripheral resistance.
-
Cardiovascular Protective Core: Reduces structural stress across arterial walls, actively shielding target organs like the brain, heart, and kidneys from high pressure strain.
-
Trusted Quality: Manufactured under strict pharmaceutical parameters of DH, ensuring precise dosing uniformity and excellent bioavailability.
Directions for Use
-
Take exactly as directed by your cardiologist, nephrologist, or primary physician.
-
Telesky AC 40/5/12.5 can comfortably be taken either with or without food. However, it is highly recommended to take your dose at the exact same time every single day (preferably in the morning) to maintain stable plasma baselines and prevent nighttime urination disruptions.
-
Swallow the tablet whole with a full glass of plain water. Do not crush, break, or chew it.
-
Important Packing Rule: Telmisartan-containing tablets absorb moisture from the atmosphere very rapidly. Only remove a single tablet from the moisture-proof blister foil configuration at the exact moment of consumption. Do not leave tablets loose inside plastic pillboxes.
Safety & Precautions
-
Do not modify your dose or halt usage suddenly without professional medical instruction, as blood pressure metrics can rise sharply behind tracking boundaries.
-
Contraindicated in Pregnancy: Do not use this product if you are pregnant, planning a pregnancy, or nursing. Telmisartan acts directly on the renin-angiotensin system and can cause severe harm or fetal death if used during the second and third trimesters.
-
Monitor your electrolyte panels (especially serum potassium, sodium, and uric acid metrics) regularly, as maximum-strength triple therapies require routine clinical tracking to preserve normal metabolic baselines.
-
Inform your specialist before initialization if you have an underlying history of severe kidney disease (anuria), liver impairment, aortic stenosis, gout, or severe dehydration parameters.
-
Avoid sudden, rapid positional movements (like jumping up quickly from a bed layout) during the initial few days of therapy to prevent temporary mild dizziness.
-
Keep out of reach of children.
Storage
-
Store in a cool, dry place below 30°C.
-
Protect from direct sunlight, excessive heat sources, and ambient environmental room moisture pools.
-
Always keep the tablets safely sealed inside their original protective blister packaging layout up until the second of intake to shield the core components from ambient room humidity.
